Abstract
Accumulating clinical evidence indicates that chronic exposure to retinoic acid (RA) may lead to depressive symptoms and even increase the risk of suicidal behavior, which severely limits the clinical long-term application of RA. The exact mechanisms through which RA contributes to the onset of depression remain largely unclear. Here, we administered intraperitoneal injections of all-trans RA to male C57BL/6 J mice over a period of 21 days. Mice subjected to chronic RA exposure displayed depressive-like behaviors, accompanied by impaired hippocampal neurogenesis and heightened RA receptor gamma (RARγ) levels in the ventral hippocampus (vHip). The administration of an RARγ antagonist effectively mitigated these RA-induced neurogenesis impairments and depressive-like behaviors. Chronic exposure to RA was also observed to promote hippocampal astrocytosis and increase astrocytic Rarγ expression in the ventral dentate gyrus (vDG) of hippocampus. Notably, astrocytic RARγ in the vDG was found to be a key factor in the observed hippocampal astrocytosis and neurogenesis impairments, and depressive-like behaviors. Chronic exposure to RA resulted in increased extracellular glutamate levels in neural stem cells (NSCs), accompanied by a decrease in glutamate transporter 1 (GLT-1) expression. Enhancing astrocytic GLT-1 expression was found to alleviate both hippocampal astrocytosis and depressive-like behaviors caused by RA. These findings underscore the critical role of astrocytic RARγ-GLT-1 axis in the development of hippocampal astrocytosis, neurogenesis impairments, and depressive symptoms, suggesting that targeting RARγ-GLT-1 could potentially offer an effective therapeutic approach for depression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 13 print issues and online access
$259.00 per year
only $19.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Marx W, Penninx B, Solmi M, Furukawa TA, Firth J, Carvalho AF. Major depressive disorder. Nat Rev Dis Primers. 2023;9:44.
Bremner JD, McCaffery P. The neurobiology of retinoic acid in affective disorders. Prog Neuro-Psychoph. 2008;32:315–31.
Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC. Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the children’s oncology group aaml1331 trial. JAMA Oncol. 2022;8:79–87.
Kocher HM, Basu B, Froeling F, Sarker D, Slater S, Carlin D. Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer. Nat Commun. 2020;11:4841.
Jones H, Blanc D, Cunliffe WJ. 13-cis retinoic acid and acne. Lancet. 1980;2:1048–9.
Bremner JD. Isotretinoin and neuropsychiatric side effects: continued vigilance is needed. J Affect Disord Rep. 2021;6:100230.
Wysowski DK, Swartz L. Relationship between headache and depression in users of isotretinoin. Arch Dermatol. 2005;141:640–1.
Otto LR, Clemens V, Usekes B, Cosma NC, Regen F, Hellmann-Regen J. Retinoid homeostasis in major depressive disorder. Transl Psychiat. 2023;13:67.
Lenz M, Kruse P, Eichler A, Straehle J, Beck J, Deller T. All-trans retinoic acid induces synaptic plasticity in human cortical neurons. Elife. 2021;10:e63026.
Hu P, Liu J, Zhao J, Qi XR, Qi CC, Lucassen PJ. All-trans retinoic acid-induced hypothalamus-pituitary-adrenal hyperactivity involves glucocorticoid receptor dysregulation. Transl Psychiat. 2013;3:e336.
Priyanka SH, Syam DS, Thushara AJ, Rauf AA, Indira M. All trans retinoic acid attenuates markers of neuroinflammation in rat brain by modulation of sirt1 and NF-kappaB. Neurochem Res. 2018;43:1791–801.
Snyder JS, Soumier A, Brewer M, Pickel J, Cameron HA. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature. 2011;476:458–61.
Berger T, Lee H, Young AH, Aarsland D, Thuret S. Adult hippocampal neurogenesis in major depressive disorder and Alzheimer’s disease. Trends Mol Med. 2020;26:803–18.
Anacker C, Hen R. Adult hippocampal neurogenesis and cognitive flexibility - linking memory and mood. Nat Rev Neurosci. 2017;18:335–46.
Boldrini M, Galfalvy H, Dwork AJ, Rosoklija GB, Trencevska-Ivanovska I, Pavlovski G. Resilience is associated with larger dentate gyrus, while suicide decedents with major depressive disorder have fewer granule neurons. Biol Psychiat. 2019;85:850–62.
Tanti A, Westphal WP, Girault V, Brizard B, Devers S, Leguisquet AM. Region-dependent and stage-specific effects of stress, environmental enrichment, and antidepressant treatment on hippocampal neurogenesis. Hippocampus. 2013;23:797–811.
Tanti A, Rainer Q, Minier F, Surget A, Belzung C. Differential environmental regulation of neurogenesis along the septo-temporal axis of the hippocampus. Neuropharmacology. 2012;63:374–84.
Kang E, Wen Z, Song H, Christian KM, Ming GL. Adult neurogenesis and psychiatric disorders. Csh Perspect Biol. 2016;8:a019026.
Surget A, Saxe M, Leman S, Ibarguen-Vargas Y, Chalon S, Griebel G. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiat. 2008;64:293–301.
Crandall J, Sakai Y, Zhang J, Koul O, Mineur Y, Crusio WE. 13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc Natl Acad Sci USA. 2004;101:5111–6.
Sakai Y, Crandall JE, Brodsky J, McCaffery P. 13-cis retinoic acid (Accutane) suppresses hippocampal cell survival in mice. Ann NY Acad Sci. 2004;1021:436–40.
Hu P, Wang Y, Liu J, Meng FT, Qi XR, Chen L. Chronic retinoic acid treatment suppresses adult hippocampal neurogenesis, in close correlation with depressive-like behavior. Hippocampus. 2016;26:911–23.
Verkhratsky A, Nedergaard M. Physiology of astroglia. Physiol Rev. 2018;98:239–389.
Zhao YF, Verkhratsky A, Tang Y, Illes P. Astrocytes and major depression: the purinergic avenue. Neuropharmacology. 2022;220:109252.
Escartin C, Galea E, Lakatos A, O’Callaghan JP, Petzold GC, Serrano-Pozo A. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24:312–25.
Novakovic MM, Korshunov KS, Grant RA, Martin ME, Valencia HA, Budinger G. Astrocyte reactivity and inflammation-induced depression-like behaviors are regulated by orai1 calcium channels. Nat Commun. 2023;14:5500.
Liddelow SA, Barres BA. Reactive astrocytes: production, function, and therapeutic potential. Immunity. 2017;46:957–67.
Wang Y, Ni J, Zhai L, Gao C, Xie L, Zhao L. Inhibition of activated astrocyte ameliorates lipopolysaccharide- induced depressive-like behaviors. J Affect Disorders. 2019;242:52–9.
de Rivero VJ, Minkiewicz J, Wang X, De Rivero VJ, German R, Marcillo AE. Astrogliosis involves activation of retinoic acid-inducible gene-like signaling in the innate immune response after spinal cord injury. Glia. 2012;60:414–21.
Fan J, Guo F, Mo R, Chen LY, Mo JW, Lu CL. O-GlcNAc transferase in astrocytes modulates depression-related stress susceptibility through glutamatergic synaptic transmission. J Clin Invest. 2023;133:e160016.
Cao X, Li LP, Wang Q, Wu Q, Hu HH, Zhang M. Astrocyte-derived atp modulates depressive-like behaviors. Nat Med. 2013;19:773–7.
Lu CL, Ren J, Mo JW, Fan J, Guo F, Chen LY. Glucocorticoid receptor-dependent astrocytes mediate stress vulnerability. Biol Psychiat. 2022;92:204–15.
Ma S, Chen M, Jiang Y, Xiang X, Wang S, Wu Z. Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb. Nature. 2023;622:802–9.
Dong WT, Long LH, Deng Q, Liu D, Wang JL, Wang F. Mitochondrial fission drives neuronal metabolic burden to promote stress susceptibility in male mice. Nat Metab. 2023;5:2220–36.
Can A, Dao DT, Terrillion CE, Piantadosi SC, Bhat S, Gould TD. The tail suspension test. J Vis Exp. 2012;59:e3769.
Cheng J, Scala F, Blanco FA, Niu S, Firozi K, Keehan L. The Rac-GEF tiam1 promotes dendrite and synapse stabilization of dentate granule cells and restricts hippocampal-dependent memory functions. J Neurosci. 2021;41:1191–206.
Zhu X, Nedelcovych MT, Thomas AG, Hasegawa Y, Moreno-Megui A, Coomer W. Jhu-083 selectively blocks glutaminase activity in brain cd11b(+) cells and prevents depression-associated behaviors induced by chronic social defeat stress. Neuropsychopharmacol. 2019;44:683–94.
Golden SA, Covington HR, Berton O, Russo SJ. A standardized protocol for repeated social defeat stress in mice. Nat Protoc. 2011;6:1183–91.
Kim J, Kang S, Choi TY, Chang KA, Koo JW. Metabotropic glutamate receptor 5 in amygdala target neurons regulates susceptibility to chronic social stress. Biol Psychiat. 2022;92:104–15.
Shen CJ, Zheng D, Li KX, Yang JM, Pan HQ, Yu XD. Cannabinoid CB(1) receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior. Nat Med. 2019;25:337–49.
Wang Q, Lin Z, Wang Z, Ye L, Xian M, Xiao L. Rargamma activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway. Blood. 2022;139:59–72.
Asrican B, Wooten J, Li YD, Quintanilla L, Zhang F, Wander C. Neuropeptides modulate local astrocytes to regulate adult hippocampal neural stem cells. Neuron. 2020;108:349–66.
Chan TJ, Her LS, Liaw HJ, Chen MC, Tzeng SF. Retinoic acid mediates the expression of glutamate transporter-1 in rat astrocytes through genomic RXR action and non-genomic protein kinase c signaling pathway. J Neurochem. 2012;121:537–50.
Marvin JS, Scholl B, Wilson DE, Podgorski K, Kazemipour A, Muller JA. Stability, affinity, and chromatic variants of the glutamate sensor iGluSnFR. Nat Methods. 2018;15:936–9.
Shearer KD, Stoney PN, Morgan PJ, McCaffery PJ. A vitamin for the brain. Trends Neurosci. 2012;35:733–41.
Hu P, van Dam AM, Wang Y, Lucassen PJ, Zhou JN. Retinoic acid and depressive disorders: evidence and possible neurobiological mechanisms. Neurosci Biobehav R. 2020;112:376–91.
Sundstrom A, Alfredsson L, Sjolin-Forsberg G, Gerden B, Bergman U, Jokinen J. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. BMJ. 2010;341:c5812.
Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene. 2004;328:1–16.
Shibata M, Pattabiraman K, Lorente-Galdos B, Andrijevic D, Kim SK, Kaur N. Regulation of prefrontal patterning and connectivity by retinoic acid. Nature. 2021;598:483–8.
Li S, Fang Y, Zhang Y, Song M, Zhang X, Ding X. Microglial nlrp3 inflammasome activates neurotoxic astrocytes in depression-like mice. Cell Rep. 2022;41:111532.
Yu G, Cao F, Hou T, Cheng Y, Jia B, Yu L. Astrocyte reactivation in medial prefrontal cortex contributes to obesity-promoted depressive-like behaviors. J Neuroinflamm. 2022;19:166.
Song H, Stevens CF, Gage FH. Astroglia induce neurogenesis from adult neural stem cells. Nature. 2002;417:39–44.
Platel JC, Dave KA, Gordon V, Lacar B, Rubio ME, Bordey A. Nmda receptors activated by subventricular zone astrocytic glutamate are critical for neuroblast survival prior to entering a synaptic network. Neuron. 2010;65:859–72.
Aida T, Yoshida J, Nomura M, Tanimura A, Iino Y, Soma M. Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in mice. Neuropsychopharmacol. 2015;40:1569–79.
Ghezali G, Dallerac G, Rouach N. Perisynaptic astroglial processes: dynamic processors of neuronal information. Brain Struct Funct. 2016;221:2427–42.
Fullana MN, Ruiz-Bronchal E, Ferres-Coy A, Juarez-Escoto E, Artigas F, Bortolozzi A. Regionally selective knockdown of astroglial glutamate transporters in infralimbic cortex induces a depressive phenotype in mice. Glia. 2019;67:1122–37.
Huang YJ, Hung CC, Hsu PC, Lee PY, Tsai YA, Hsin YC. Astrocytic aryl hydrocarbon receptor mediates chronic kidney disease-associated mental disorders involving glt1 hypofunction and neuronal activity enhancement in the mouse brain. Glia. 2023;71:1057–80.
Rosenfeld MG, Lunyak VV, Glass CK. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Gene Dev. 2006;20:1405–28.
Yasuhara R, Yuasa T, Williams JA, Byers SW, Shah S, Pacifici M. Wnt/beta-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover. J Biol Chem. 2010;285:317–27.
Acknowledgements
We thank Chunhua Yuan, Lirong Sun, Shuji Li, Yingying Fang, and Ting Guo (Southern Medical University) for their technical support.
Funding
The work was supported by the National Natural Science Foundation of China (81971234), Natural Science Foundation of Guangdong Province, China (2022A1515012248), the Key Area Research and Development Program of Guangdong Province (2018B030334001 and 2018B030340001), the Science and Technology Program of Guangzhou (202007030013), and Guangdong-Hong Kong Joint Laboratory for Psychiatric Disorders (2023B1212120004).
Author information
Authors and Affiliations
Contributions
XMW and HXH designed the study and wrote the paper. BT reviewed and edited the manuscript. HXH analyzed the data. HXH performed most of the experiments with the help of WSL and RL. RL and YYZ performed the real-time quantitative PCR experiment. XHS performed some immunofluorescence experiments. YQZ was responsible for animal care. XYZ performed HPLC experiment with the help of YYZ. XMW and BT supervised all phases of the project.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Huang, H., Lu, W., Luo, R. et al. Astrocytic RARγ mediates hippocampal astrocytosis and neurogenesis deficits in chronic retinoic acid-induced depression. Neuropsychopharmacol. (2024). https://doi.org/10.1038/s41386-024-01983-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41386-024-01983-3